Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 26:17:465-476.
doi: 10.2147/CCID.S451288. eCollection 2024.

Clinical Misdiagnosis of Cutaneous Malignant Tumors as Melanocytic Nevi or Seborrheic Keratosis: A Retrospective Analysis of a Chinese Population

Jun Zhang  1 , Yu Wang  1 , Wei Zhang  1 , Linglong Cai  1 , Jianglong Feng  2 , Yiwei Zhu  1 , Hongguang Lu  1
Affiliations

Clinical Misdiagnosis of Cutaneous Malignant Tumors as Melanocytic Nevi or Seborrheic Keratosis: A Retrospective Analysis of a Chinese Population

Jun Zhang et al. Clin Cosmet Investig Dermatol. .

Abstract

Purpose: The rising incidence and mortality associated with cutaneous malignant tumours highlight the importance of early diagnosis of these tumors. In clinical practice, these tumors are often misdiagnosed as benign skin lesions such as melanocytic nevi (MN) and seborrheic keratosis (SK) because of their similar morphologic features. The incidence and clinicopathological subtypes of cutaneous malignancies in East Asia populations significantly differ from those in fair-skinned groups. However, studies on misdiagnoses in Eastern countries are lacking. Therefore, this study focused on the clinical and pathological features of cutaneous malignant tumors misdiagnosed as MN or SK in a Chinese population.

Patients and methods: A total of 4592 samples clinically diagnosed as MN (n = 3503) or SK (n = 1089) from July 2014 to June 2022 were collected and evaluated retrospectively. The clinical and pathological data were analyzed to identify associated factors.

Results: Pathological assessments showed that 2.5% (86/3503) of the specimens clinically diagnosed as MN were malignancies, predominantly basal cell carcinoma (BCC, 84.9%, 73/86), followed by malignant melanoma (MM, 8.1%, 7/86) and squamous cell carcinoma (SCC, 7.0%, 6/86). Similarly, 5.7% (62/1089) of the specimens clinically diagnosed as SK were malignant tumors, of which BCC (50.0%, 31/62) was the most common, followed by SCC (41.9%, 26/62) and MM (8.1%, 5/62). In both types of specimens, advanced age and facial lesions were risk factors for malignancy misdiagnosis. The malignancy rate, mean age, and proportion of SCC in the specimens clinically diagnosed as SK were higher than those in the specimens clinically diagnosed as MN. Dermoscopy significantly reduced the rate of misdiagnosis of these tumors as MN or SK.

Conclusion: In China, cutaneous malignant tumors misdiagnosed as MN or SK are not uncommon in clinical practice, and active introduction of noninvasive diagnostic techniques is essential to distinguish them.

Keywords: China; basal cell carcinoma; dermoscopy; malignant melanoma; skin benign neoplasms; squamous cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Jun Zhang, Yu Wang, Wei Zhang; Linglong Cai, Jianglong Feng, Yiwei Zhu and Hongguang Lu have no conflicts of interest that are directly relevant to the content of this article.

Figures

Figure 1
Figure 1
Age distribution of the patients whose specimens were submitted.
Figure 2
Figure 2
Location distribution of the submitted specimens.
See this image and copyright information in PMC

References

    1. Urban K, Mehrmal S, Uppal P, Giesey RL, Delost GR. The global burden of skin cancer: a longitudinal analysis from the global burden of disease study, 1990–2017. JAAD international. 2021;2:98–108. doi:10.1016/j.jdin.2020.10.013 - DOI - PMC - PubMed
    1. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (Concord-3): analysis of individual records for 37513025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075. doi:10.1016/s0140-6736(17)33326-3 - DOI - PMC - PubMed
    1. Vaz-Luis I, Masiero M, Cavaletti G, et al. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. Ann Oncol. 2022;33:1119–1133. doi:10.1016/j.annonc.2022.07.1941 - DOI - PubMed
    1. Liu P, Su J, Zheng X, et al. Clinicopathological analysis of melanocytic nevi: a retrospective series. Front Med Lausanne. 2021;8:681668. doi:10.3389/fmed.2021.681668 - DOI - PMC - PubMed
    1. Reeck MC, Chuang TY, Eads TJ, Faust HB, Farmer ER, Hood AF. The diagnostic yield in submitting nevi for histologic examination. J Am Acad Dermatol. 1999;40:567–571. doi:10.1016/s0190-9622(99)70456-1 - DOI - PubMed